Cite
A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients
MLA
Ester Orlandi, et al. A Phase II Multi-Center Trial of Pentostatin plus Cyclophosphamide with Ofatumumab in Older Previously Untreated Chronic Lymphocytic Leukemia Patients. Dec. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0110d842fa313a65db51bbd2fd31d034&authtype=sso&custid=ns315887.
APA
Ester Orlandi, Marco Montillo, Marianna Rossi, Lydia Scarfò, Giulia Quaresmini, Gianluca Gaidano, Agostino Cortelezzi, Guido Nador, Antonella Anastasia, Lorenzo De Paoli, Davide Rossi, Marina Motta, Daniela Dalceggio, Anna Maria Frustaci, Fausto Rossini, Marta Coscia, Massimo Massaia, Alessandro Rambaldi, Alessandra Tedeschi, … Paola Picardi. (2015). A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.
Chicago
Ester Orlandi, Marco Montillo, Marianna Rossi, Lydia Scarfò, Giulia Quaresmini, Gianluca Gaidano, Agostino Cortelezzi, et al. 2015. “A Phase II Multi-Center Trial of Pentostatin plus Cyclophosphamide with Ofatumumab in Older Previously Untreated Chronic Lymphocytic Leukemia Patients,” December. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0110d842fa313a65db51bbd2fd31d034&authtype=sso&custid=ns315887.